ELDN
NASDAQ
US
Eledon Pharmaceuticals, Inc. - Common Stock
$3.07
▲ +$0.07
(+2.33%)
Vol 1.2M
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$113.4M
ROE
-74.6%
D/E
0.00
Beta
0.93
52W
$1–$5
Wall Street Consensus
13 analysts · Apr 20264
Strong Buy
8
Buy
1
Hold
0
Sell
0
Strong Sell
92.3%
Buy Rating
Price Chart
Similar Stocks
IKT
Inhibikase Therapeutics Inc
$248.6M
KROS
Keros Therapeutics Inc
P/E 9.6
$620.3M
VYGR
Voyager Therapeutics Inc
$218.5M
RNA
Atrium Therapeutics Inc
$10.9B
CAMP
CAMP4 Therapeutics Corp
$318.0M
NERV
Minerva Neurosciences Inc
$28.1M
ARCT
Arcturus Therapeutics Holdings Inc
$174.2M
FENC
Fennec Pharmaceuticals Inc
$262.9M
Earnings
Beat rate: 100.0%
Next Report
May 12, 2026
EPS Estimate: $-0.22
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.22 | — | — |
| Dec 2025 | $-0.21 | $-0.10 | +$0.11 |
| Sep 2025 | $-0.26 | $-0.21 | +$0.05 |
| Jun 2025 | $-0.23 | $-0.13 | +$0.10 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 13.8% | 14.1% | 14.1% | 14.1% | -74.2% | -74.6% |
| P/E (TTM) | 11.36 | 10.55 | 10.88 | 17.67 | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 8.12 | 8.12 | 8.12 | 8.12 | 6.74 | 6.74 |
Key Ratios
ROA (TTM)
-52.3%
P/B
2.1
EPS (TTM)
$-1.10
CF/Share
$-2.83
52W High
$4.98
52W Low
$1.35
$1.35
52-Week Range
$4.98
How does ELDN compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ELDN valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
2.1
▼
15%
below
peers
(2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ELDN profitability vs Biotechnology peers
ROE
-74.6%
▼
11%
below
peers
(-67.3%)
vs Peers
vs Industry
In line
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-52.3%
▼
12%
below
peers
(-46.7%)
vs Peers
vs Industry
In line
ELDN financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
6.7
▲
52%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
0.9
▼
4%
below
peers
(1.0)
vs Peers
vs Industry
Less volatile
ELDN fundamentals radar
ELDN
Peer median
Industry
ELDN profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ELDN vs peers: key metrics
Latest News
No related news yet